2023
DOI: 10.1097/spc.0000000000000651
|View full text |Cite
|
Sign up to set email alerts
|

Vitamin D is a potential treatment for the management of gastrointestinal mucositis

Fizza Munem,
Phir C.K. Thianhlun,
Paul H. Anderson
et al.

Abstract: Purpose of the review Gastrointestinal mucositis (GM) is a severe side effect of cancer treatments, negatively impacting the patient’s quality of life, and has limited treatment. GM consists of complex biological processes involving apoptosis and inflammation, leading to damage and ulceration of the gastrointestinal system. Recently, vitamin D has been shown to have multiple roles in the gut, including immunomodulation, epithelial barrier regulation and microbiome regulation. Hence, this review aim… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2024
2024
2025
2025

Publication Types

Select...
4
1

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(1 citation statement)
references
References 49 publications
0
1
0
Order By: Relevance
“…Bacillus coagulans MZY531 ameliorated CYP-induced intestinal mucosal injury and inflammation by upregulating the ZO-1 pathway and downregulating the expression of the TLR4/MyD88/NF-ĸB pathway [52]. Unfortunately third-party fecal microbiota transplantation in hematology patients was safe but did not decrease infections in this randomized double-blind phase II trial [53 ▪ ]. Diet components such as vitamin D are promising as prebiotics often in combination, and result in downregulation of inflammation and harnessing integrity [54].…”
Section: Gastrointestinal Mucositis As Target For Preventing Inflamma...mentioning
confidence: 99%
“…Bacillus coagulans MZY531 ameliorated CYP-induced intestinal mucosal injury and inflammation by upregulating the ZO-1 pathway and downregulating the expression of the TLR4/MyD88/NF-ĸB pathway [52]. Unfortunately third-party fecal microbiota transplantation in hematology patients was safe but did not decrease infections in this randomized double-blind phase II trial [53 ▪ ]. Diet components such as vitamin D are promising as prebiotics often in combination, and result in downregulation of inflammation and harnessing integrity [54].…”
Section: Gastrointestinal Mucositis As Target For Preventing Inflamma...mentioning
confidence: 99%